Deutsche Bank’s ADC Therapeutics ADCT Stock Holding History

Deutsche Bank’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.3K	Buy	83,444 +3,239	+4%	+$9.45K	﹤0.01%	3501
2026 Q1	$301K	Buy	80,205 +9,431	+13%	+$37.2K	﹤0.01%	2828
2025 Q4	$250K	Sell	70,774 -6,750	-9%	-$27.4K	﹤0.01%	2914
2025 Q3	$310K	Buy	77,524 +21,462	+38%	+$67.7K	﹤0.01%	2828
2025 Q2	$150K	Hold	56,062	–	–	﹤0.01%	3096
2025 Q1	$79K	Hold	56,062	–	–	﹤0.01%	3268
2024 Q4	$112K	Buy	56,062 +16,217	+41%	+$42.4K	﹤0.01%	3262
2024 Q3	$126K	Buy	39,845 +95	+0.2%	+$300	﹤0.01%	3142
2024 Q2	$126K	Buy	+39,750	New	+$158K	﹤0.01%	3035
2021 Q4	–	Sell	-300	Closed	-$8K	–	4234
2021 Q3	$8K	Buy	+300	New	+$7.68K	﹤0.01%	4300

Other funds holding ADCT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank's ADCT Position: Q2 2026 in Review

Deutsche Bank increased its ADC Therapeutics (ADCT) stake by 4% in Q2 2026, buying an estimated $9.45K and bringing the position to 83,444 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3501.

Deutsche Bank first reported a position in ADCT in Q3 2021 and has held it in 10 quarters since. The position peaked at $310K in Q3 2025. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

Deutsche Bank held 83,444 shares of ADC Therapeutics worth $89.3K as of Q2 2026.
Deutsche Bank bought 3,239 ADC Therapeutics shares in Q2 2026, an estimated $9.45K.
ADC Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3501 holding.
Deutsche Bank first reported a position in ADC Therapeutics in Q3 2021 and has held it in 10 quarters since.
Deutsche Bank's ADC Therapeutics position peaked at $310K in Q3 2025.
114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.